Aarti Drugs Limited — Board Meeting, 06-05-2025: Outcome of Board Meeting

Aarti Drugs Limited has announced a board meeting approving the financial results for the quarter and half-year. Consolidated revenue was Rs. 2,26,691 lakhs with a net profit of Rs. 14,327 lakhs. The company completed a buyback of 6.65 lakh shares at Rs. 900 each, cutting paid-up equity to Rs. 91.27 Cr. M/s GMVP & Associates LLP has been re-appointed as cost auditor for FY26. Operations remain focused on pharmaceuticals, backed by steady cash flows and moderate borrowings.